Sign in

CIK 0001388320

  • Non-accelerated filer
  • Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880378336
Phone
+1 646-677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-08-12 Ludwig Dale L. Chief Science & Tech. Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2019-07-12 Ludwig Dale L. Chief Scientific Officer Grant or award · Options to purchase common stock +400,000 $0.23 $93K 400,000
2018-11-19 Ludwig Dale L. Chief Scientific Officer Purchase +10,000 $0.45 $4K 10,000

Page 1 of 1 · 3 trades